Apimeds Pharmaceuticals US Files for 3.33M Share IPO at $3-$4/sh
Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share. This post appeared first on investing.com
Read more
Investing
Airbnb, Trump Media, Affirm fall premarket;Rivian, Lucid rise
Investing.com — US stock futures edged higher Friday, continuing the post-election rally after Donald Trump won the US presidency and...
Read more
Walmart to offer independent drivers new holiday bonuses in battle with Amazon
By Siddharth Cavale NEW YORK (Reuters) – Walmart (NYSE:WMT) will pay independent delivery drivers new financial incentives to pick up...
Read more
Richemont shares fall amid sluggish China demand, margin pressures
Investing.com — Shares of Richemont (SIX:CFR) fell over 6% on Friday following its first-half results, as weak demand from China...
Read more
Brazilian planemaker Embraer’s third-quarter profit soars to $207 million
SAO PAULO (Reuters) – Brazilian planemaker Embraer’s third-quarter adjusted net profit soared to 1.18 billion reais ($207.30 million) from 167...
Read more
Bombardier’s third-quarter revenue rises 12% on services business boost
(Reuters) – Bombardier (OTC:BDRBF) said on Thursday its third-quarter revenue rose 12%, helped by strong demand for business jet parts...
Read more
Carlyle third-quarter profit tops Wall St view on higher fee income
By Echo Wang NEW YORK (Reuters) – Private equity firm Carlyle Group (NASDAQ:CG) posted flat third-quarter profits but beat Wall...
Read more
Playtika earnings missed by $0.07, revenue fell short of estimates
Investing.com – Playtika (NASDAQ: PLTK) reported third quarter EPS of $0.11, $0.07 worse than the analyst estimate of $0.18. Revenue...
Read more
